TRAC-ER Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals (TRAC-ER)

March 20, 2024 updated by: Carolyn Lauckner

Evaluation of a Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals

Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use. A mobile app has been developed that uses GPS tracking to determine when emerging adult sexual minority male and transgender (SMMTs) persons visit "risky" places and then delivers a survey asking what behaviors they engaged in while at the location.

The goal of the proposed study is to use this app to enhance the Tracking and Reducing Alcohol Consumption (TRAC) intervention by delivering messages that encourage participants to employ strategies discussed during TRAC sessions when arriving at risky places. When they leave these places, they will complete a survey and breathalyzer reading in order to collect event-level self-report and biological data on alcohol use and HIV risk. If their breathalyzer result indicates alcohol use, they will receive harm reduction messaging. It is expected that combining TRAC with EMI ("TRAC-ER") will increase effectiveness by reinforcing topics discussed during these sessions, providing in-the-moment messaging to address triggers, and collecting real-time alcohol use data.

Study Overview

Detailed Description

For this study, the investigators will enhance an existing mHealth intervention (TRAC) to reduce alcohol use among SMMT individuals by combining the intervention with an app which delivers EMI messages in real-time. Upon enrollment, participants will be randomized into one of 3 arms: TRAC-ER (EMI messaging, TRAC intervention, and smartphone-based alcohol monitoring), TRAC (TRAC intervention and smartphone-based alcohol monitoring), or a comparison group (smartphone-based alcohol monitoring only).

Participants will be recruited from Kentucky and Connecticut through community-based recruitment and health clinics that serve SMMT individuals.

Preliminary data used for this study were collected from a study (PI: Lauckner, K01AA02530) testing the TRAC intervention with people living with HIV/AIDS, which has shown promising preliminary results, with high feasibility, acceptability, and encouraging preliminary outcomes.

Study Type

Interventional

Enrollment (Estimated)

405

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06520
    • Kentucky
      • Lexington, Kentucky, United States, 40536

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • self-identify as a sexual minority male (i.e., identifies as male and as a sexual orientation other than heterosexual) or as a transgender individual
  • is between the ages of 18-35 at the start of the study
  • owns a smartphone
  • is HIV-negative (confirmed through a test at baseline)
  • screens positively for at-risk alcohol use
  • meets CDC PrEP eligibility criteria

Exclusion Criteria:

  • do not speak English
  • active psychosis or severe mental illness
  • are actively detoxifying from substances and need medical supervision
  • a score of 23 or greater on the Alcohol Withdrawal Symptom Checklist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SAM-Only Comparison Group
Participants in this group will engage only in smartphone-based alcohol monitoring.
Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.
Experimental: TRAC plus SAM
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention and smartphone-based alcohol monitoring.
Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.
The TRAC intervention focuses on increasing motivation and building skills for avoiding triggers and managing situations that encourage drinking. It requires four 30-minute sessions with a counselor using videoconferencing and mobile phones. In addition to receiving the four sessions of intervention content, participants will complete smartphone-based self-monitoring of medication adherence and alcohol consumption, which will be discussed during intervention sessions.
Experimental: TRAC-ER plus SAM
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention combined with GPS-based ecological momentary interventions (EMI) and smartphone-based alcohol monitoring.
Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.
The TRAC intervention focuses on increasing motivation and building skills for avoiding triggers and managing situations that encourage drinking. It requires four 30-minute sessions with a counselor using videoconferencing and mobile phones. In addition to receiving the four sessions of intervention content, participants will complete smartphone-based self-monitoring of medication adherence and alcohol consumption, which will be discussed during intervention sessions.
Ecological momentary interventions (EMI) use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of drinking days
Time Frame: 8 months (measured twice daily)
Number of days in which alcohol was consumed based on breathalyzer readings greater than 0.00
8 months (measured twice daily)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of binge drinking episodes
Time Frame: 8 months (measured daily)
Number of binge drinking episodes (occasions when participants had 5+ drinks based on self-reported number of drinks)
8 months (measured daily)
Number of drinks/drinking day
Time Frame: 8 months (measured daily)
Number of drinks per drinking day
8 months (measured daily)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol withdrawal
Time Frame: 8 months (measured daily)
Alcohol withdrawal symptom severity on a scale of 0-9, Alcohol Withdrawal Symptom Checklist
8 months (measured daily)
Hazardous/harmful drinking
Time Frame: 8 months
PROMIS SF Alcohol Use 7a, asks about hazardous/harmful drinking behaviors (e.g., drank too much, drank heavily). Scores range from 7-35, higher scores mean more hazardous/harmful drinking behaviors.
8 months
Rate of alcohol use
Time Frame: 8 months
Number of self-reported drinking days reported via Timeline Followback
8 months
Alcohol cravings
Time Frame: 8 months
Individual thinking about alcohol and drinking behavior (Obsessive Compulsive Drinking Scale, scores ranging from 0-56; higher scores indicate higher rates of alcohol cravings)
8 months
Alcohol consequences
Time Frame: 8 months

Perceived negative consequences of using alcohol (e.g., unreliable, social problems, judgement; PROMIS SF Alcohol Use- Negative Consequences 7a). Scores range from 7-35; higher scores mean more perceived negative consequences.

Perceived positive consequences of using alcohol (e.g., self-esteem, confidence, enjoyment; PROMIS SF Alcohol Use- Positive Consequences 7a). Scores range from 7-35; higher scores mean more perceived positive consequences.

8 months
Alcohol expectancies
Time Frame: 8 months

Negative expectancies of alcohol use (e.g., making bad decisions, rudeness; PROMIS SF Alcohol Use- Negative Expectancies 7a). Scores range from 7-35; higher scores mean more negative expectancies.

Positive expectancies of alcohol use (e.g., improves mood, improves sociability; PROMIS SF Alcohol Use- Positive Expectancies 7a). Scores range from 7-35; higher scores mean more positive expectancies.

8 months
Readiness to change drinking
Time Frame: 8 months
Stage of change toward reducing alcohol use (precontemplation, contemplation, action)- Readiness to Change Questionnaire (scores ranging from -24 to +24; higher positive scores indicate a greater readiness to change drinking habits)
8 months
Drinking refusal self-efficacy
Time Frame: 8 months
Individuals' belief in their ability to resist alcohol (Drinking Refusal Self-Efficacy Questionnaire-R; 3 subscales: social pressure drinking, emotional relief drinking, opportunistic drinking. Scores range from 0-114; higher scores indicate higher rates of refusal to drink.)
8 months
Condom attitudes
Time Frame: 8 months
Attitudes towards condoms across 7 factors: reliability and effectiveness, pleasure, identity stigma, embarrassment about purchase, negotiation, and action maintenance (Multidimensional Condom Attitudes Scale; scores range from 16-112; higher scores indicate more positive attitudes about condoms.)
8 months
Perceived HIV risk
Time Frame: 8 months
Likelihood estimates, intuitive judgements, and salience of HIV risk based on previous behaviors (Perceived Risk of HIV Scale). Scores range from 10-40; higher scores indicate higher risk perception.
8 months
Discrimination due to sexual/gender identity
Time Frame: 8 months
Harassment, rejection, and family discrimination related to LGBTQ identities (Heterosexist Harassment, Rejection, and Discrimination Scale). Scores range from 12-72; higher scores indicate more frequent occurrences of harassment/rejection/discrimination.
8 months
Sexual activity
Time Frame: 8 months (measured daily)
Engaged in sexual activity on previous day (percentage of respondents answering yes or no)
8 months (measured daily)
Characteristics of sex partners
Time Frame: 8 months (measured daily)
If applicable; number, type (percentage of respondents answering primary or non-primary partners), HIV status of partner(s) (percentage of respondents answering positive or negative status)
8 months (measured daily)
PrEP use
Time Frame: 8 months (measured daily)
Used PrEP on previous day (percentage of respondents answering yes or no)
8 months (measured daily)
Condomless sex
Time Frame: 8 months
If applicable; frequency of condomless sex for primary/non-primary partners assessed using a 5-point Likert scale ranging from "never" to "always"
8 months
Transactional sex
Time Frame: 8 months
Engagement in transactional sex (percentage of respondents answering yes or no)
8 months
Concurrent sex and substance use
Time Frame: 8 months
Engagement in concurrent sex and substance use (percentage of respondents answering yes or no)
8 months
Location characteristics - substances
Time Frame: 8 months (assessed up to 2x daily)
Substances used by participant at location (check all that apply from list if used yes/no; percentage of "yes" responses for each substance out of all location surveys completed by participant)
8 months (assessed up to 2x daily)
Location characteristics - sexual activity
Time Frame: 8 months (assessed up to 2x daily)
Sexual activity engaged in at location (yes/no; percentage of "yes" responses out of all location surveys completed by participant)
8 months (assessed up to 2x daily)
Location characteristics - harassment/discrimination
Time Frame: 8 months (assessed up to 2x daily)
Experienced harassment/discrimination at location (check all that apply from list: physical, emotional, or sexual harassment; percentage of "yes" responses for each type of harassment/discrimination out of all location surveys completed by participant)
8 months (assessed up to 2x daily)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Trace Kershaw, PhD, Yale University
  • Principal Investigator: Carolyn Lauckner, PhD, University of Kentucky

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

September 29, 2022

First Submitted That Met QC Criteria

October 7, 2022

First Posted (Actual)

October 12, 2022

Study Record Updates

Last Update Posted (Actual)

March 21, 2024

Last Update Submitted That Met QC Criteria

March 20, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV Infections

Clinical Trials on Smartphone Based Alcohol Monitoring (SAM)

3
Subscribe